Springworks Therapeutics Inc (SWTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 69,751 | 176,053 | 67,490 | 103,961 | 147,089 |
| Marketable Securities | 238,234 | 303,149 | 524,722 | 269,540 | 361,395 |
| Receivables | 46,238 | 5,930 | N/A | N/A | N/A |
| Inventories | 10,212 | 3,103 | N/A | N/A | N/A |
| TOTAL | $380,465 | $500,912 | $599,760 | $382,910 | $513,398 |
| Non-Current Assets | |||||
| PPE Net | 19,680 | 17,943 | 13,571 | 3,187 | 1,075 |
| Investments And Advances | 158,123 | 185,341 | 8,987 | 62,113 | 57,207 |
| Other Non-Current Assets | 29,008 | 21,592 | 7,924 | 4,284 | 4,511 |
| TOTAL | $206,811 | $224,876 | $30,482 | $69,584 | $62,793 |
| Total Assets | $587,276 | $725,788 | $630,242 | $452,494 | $576,191 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 12,248 | 7,396 | 8,010 | 3,429 | 1,350 |
| Accrued Expenses | 86,012 | 65,569 | 39,242 | 25,378 | 14,885 |
| TOTAL | $99,990 | $78,170 | $51,049 | $29,969 | $17,610 |
| Non-Current Liabilities | |||||
| Deferred Revenues | N/A | 4,144 | 3,314 | N/A | N/A |
| Other Non-Current Liabilities | 6,182 | 5,996 | 4,768 | 129 | 1,523 |
| TOTAL | $6,182 | $21,399 | $21,001 | $129 | $1,523 |
| Total Liabilities | $106,172 | $99,569 | $72,050 | $30,098 | $19,133 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 74,936 | 73,787 | 62,499 | 49,344 | 48,976 |
| Common Shares | 7 | 7 | 6 | 5 | 5 |
| Retained earnings | -1,153,165 | -895,034 | -569,930 | -292,513 | -118,603 |
| Other shareholders' equity | 725 | 1,050 | -1,108 | -312 | 41 |
| TOTAL | $481,104 | $626,219 | $558,192 | $422,396 | $557,058 |
| Total Liabilities And Equity | $587,276 | $725,788 | $630,242 | $452,494 | $576,191 |